资源类型:
期刊
WOS体系:
Correction
Pubmed体系:
Published Erratum
收录情况:
◇ SCIE
文章类型:
修订
作者:
Zhang, Lei-Ke[1]
*
;
Sun, Yuan[1,2]
;
Zeng, Haolong[3]
;
Wang, Qingxing[1,2]
;
Jiang, Xiaming[1,2]
;
Shang, Wei-Juan[1]
;
Wu, Yan[1]
;
Li, Shufen[1]
;
Zhang, Yu-Lan[1]
;
Hao, Zhao-Nian[4]
;
Chen, Hongbo[5]
;
Jin, Runming[5]
;
Liu, Wei[6]
;
Li, Hao[6]
;
Peng, Ke[1]
;
Xiao, Gengfu[1,2]
;
单位:
[1]Chinese Acad Sci, Ctr Biosafety Mega Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Hubei, Peoples R China
[2]Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[3]Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Lab Med, Tongji Hosp, Wuhan 430030, Hubei, Peoples R China
检验科
华中科技大学同济医学院附属同济医院
[4]Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China
[5]Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Pediat, Wuhan 430022, Hubei, Peoples R China
华中科技大学同济医学院附属协和医院
[6]Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China
ISSN:
2056-5968
被引次数:
1
WOS:
WOS:000646551000001
PubmedID:
33941764
中科院(CAS)分区:
出版当年[2020]版:
大类
|
2 区
生物
小类
|
2 区
细胞生物学
最新[2025]版:
大类
|
1 区
生物学
小类
|
1 区
细胞生物学
JCR分区:
出版当年[2019]版:
Q1
CELL BIOLOGY
最新[2023]版:
Q1
CELL BIOLOGY
影响因子:
13
最新[2023版]
14.8
最新五年平均
6.255
出版当年[2019版]
5.624
出版当年五年平均
4.6
出版前一年[2018版]
10.849
出版后一年[2020版]
第一作者:
Zhang, Lei-Ke
第一作者单位:
[1]Chinese Acad Sci, Ctr Biosafety Mega Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Hubei, Peoples R China
通讯作者:
Li, Hao
推荐引用方式(GB/T 7714):
Zhang Lei-Ke,Sun Yuan,Zeng Haolong,et al.Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension (vol 6, 96, 2020)[J].CELL DISCOVERY.2021,7(1):doi:10.1038/s41421-021-00267-0.
APA:
Zhang, Lei-Ke,Sun, Yuan,Zeng, Haolong,Wang, Qingxing,Jiang, Xiaming...&Xiao, Gengfu.(2021).Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension (vol 6, 96, 2020).CELL DISCOVERY,7,(1)
MLA:
Zhang, Lei-Ke,et al."Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension (vol 6, 96, 2020)".CELL DISCOVERY 7..1(2021)